Symbol: |
FGF9
|
Description: |
fibroblast growth factor 9 (glia-activating factor) [Source:HGNC Symbol;Acc:3687]
|
Location: |
Chr13:22245522-22278637[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:261
Gene |
Compound |
Gen_sig |
Exp_pattern |
FGF9 |
NSC 720666 |
0.022 |
Down |
FGF9 |
6,7-dimethyl-1,4-di-N-oxide-3-methylquinoxalin-2-yl-4-(4-nit rophenyl)piperazinyl ketone |
0.042 |
Up |
FGF9 |
NSC 720794 |
0.021 |
Down |
FGF9 |
2-fluorphenylhydrazone alpha-lapachone |
0.032 |
Up |
FGF9 |
(-)-Dibenzylnortrachelogenin |
0.049 |
Up |
FGF9 |
NSC 722388 |
0.003 |
Down |
FGF9 |
NSC 722398 |
0.043 |
Down |
FGF9 |
4-[4-(2-Diethylamino-ethylamino)-naphthalen-1-ylazo]-benzene sulfonamide |
0.039 |
Down |
FGF9 |
NSC 722985 |
0.037 |
Down |
FGF9 |
(1S,4R,5R,8R,12R,13S)-1,5-dimethyl-9-methylene-11,14,15,16-t etraoxatetracyclo[10.3.1.04,13.08,13]hexadec-10-yl]oxy}-3-he xenyl)oxy]-1,5,-dimethyl-9-methylene-11,14,15,16-tetraoxatet racyclo[10.3.1.04,13.08,13]hexadecane |
0.047 |
Down |
FGF9 |
Waol A FD-211 |
0.023 |
Down |
FGF9 |
2,2'-(1,4-phenylene)bis(1,3-dimethylimidazolidine) |
0.012 |
Down |
FGF9 |
NSC 726881 |
0.007 |
Down |
FGF9 |
Dasatinib |
0.001 |
Up |
FGF9 |
NSC 733155 |
0.039 |
Down |
Expression pattern: Sensitivity / Resistance
Total:18 Current:16
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:56
Total:4 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:4
Gene |
Gen_transcript |
miRNA |
miR_location |
FGF9 |
ENST00000382353 |
hsa-mir-182-5p |
Chr7:129410287-129410310[-] |
FGF9 |
ENST00000382353 |
hsa-mir-27b-5p |
Chr9:97847745-97847766[+] |
FGF9 |
ENST00000382353 |
hsa-mir-365a-3p |
Chr16:14403197-14403218[+] |
FGF9 |
ENST00000382353 |
hsa-mir-369-5p |
Chr14:101531943-101531964[+] |
Total:1 Current:1
[First] [Prev] [Next] [Last]
|